AGNG

Aging Population ETF

Morningstar Rating™ - Overall rating out of 164 Health funds, based on risk-adjusted returns as of 08/31/2025

Key Information

As of Sep 12 2025
Inception Date
05/09/16
Total Expense Ratio
0.50%
Net Assets
$64.96 million
NAV
$33.49
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
Trading Details
Distributions

ETF Prices

As of Sep 12 2025
NAV$33.49Daily Change-$0.24-0.71%
Market Price$33.53Daily Change-$0.31-0.92%

Performance History

Fund NAVMarket PriceIndex

Top Holdings

Net Assets (%)TickerNameSEDOLShares HeldMarket Value
Exposure

ETF Characteristics

As of Sep 12 2025
Return on Equity15.50%
Weighted Avg. Market Cap99,286 M
20242025
Price-to-earnings25.4120.96
Price-to-book value3.443.08

ETF Risk Stats

As of Aug 31 2025
VERSUSBETA
S&P 5000.64
NASDAQ-1000.39
MSCI EAFE0.62
MSCI Emg. Mkts0.44
Standard Deviation13.00%

ETF Research

Investing in Pharma: How to Spot Leading Drug Candidates

Investing in Pharma: The Drug Lifecycle

In the Pipeline: Top Drug Candidates for FDA Approval in 2024

ETF Documents